Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

152 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
OrBITS: label-free and time-lapse monitoring of patient derived organoids for advanced drug screening.
Deben C, De La Hoz EC, Compte ML, Van Schil P, Hendriks JMH, Lauwers P, Yogeswaran SK, Lardon F, Pauwels P, Van Laere S, Bogaerts A, Smits E, Vanlanduit S, Lin A. Deben C, et al. Among authors: lardon f. Cell Oncol (Dordr). 2023 Apr;46(2):299-314. doi: 10.1007/s13402-022-00750-0. Epub 2022 Dec 12. Cell Oncol (Dordr). 2023. PMID: 36508089 Free PMC article.
Targeting CD70 in combination with chemotherapy to enhance the anti-tumor immune effects in non-small cell lung cancer.
Flieswasser T, Van den Eynde A, Freire Boullosa L, Melis J, Hermans C, Merlin C, Lau HW, Van Audenaerde J, Lardon F, Smits E, Pauwels P, Jacobs J. Flieswasser T, et al. Among authors: lardon f. Oncoimmunology. 2023 Mar 23;12(1):2192100. doi: 10.1080/2162402X.2023.2192100. eCollection 2023. Oncoimmunology. 2023. PMID: 36970072 Free PMC article.
Establishment of head and neck squamous cell carcinoma mouse models for cetuximab resistance and sensitivity.
Zaryouh H, De Pauw I, Baysal H, Melis J, Van den Bossche V, Hermans C, Lau HW, Lambrechts H, Merlin C, Corbet C, Peeters M, Vermorken JB, De Waele J, Lardon F, Wouters A. Zaryouh H, et al. Among authors: lardon f. Cancer Drug Resist. 2023 Oct 17;6(4):709-728. doi: 10.20517/cdr.2023.62. eCollection 2023. Cancer Drug Resist. 2023. PMID: 38239393 Free PMC article.
Optimization of the Solvent and In Vivo Administration Route of Auranofin in a Syngeneic Non-Small Cell Lung Cancer and Glioblastoma Mouse Model.
Freire Boullosa L, Van Loenhout J, Hermans C, Lau HW, Merlin C, Marcq E, Takhsha FS, Martinet W, De Meyer GRY, Lardon F, Smits ELJ, Deben C. Freire Boullosa L, et al. Among authors: lardon f. Pharmaceutics. 2022 Dec 9;14(12):2761. doi: 10.3390/pharmaceutics14122761. Pharmaceutics. 2022. PMID: 36559255 Free PMC article.
152 results